This inventor holds 1 USPTO granted patent. Top assignee: Paean Biotechnology Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Do Won Hwang: Innovator in Pharmaceutical Composition
Introduction
Do Won Hwang is a notable inventor based in Yeongtong, Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of myositis. His innovative approach has led to the development of a unique pharmaceutical composition that utilizes isolated mitochondria as an active ingredient.
Latest Patents
Do Won Hwang holds 1 patent for his invention titled "Pharmaceutical Composition for Preventing or Treating Myositis, Comprising Isolated Mitochondria as Active Ingredient." This patent reflects his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Hwang is currently associated with Paean Biotechnology Inc., where he continues to work on groundbreaking research and development in the pharmaceutical sector. His expertise and dedication have positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Do Won Hwang has collaborated with talented individuals such as Kyuboem Han and Chun-Hyung Kim. These partnerships have fostered innovation and contributed to the success of his projects.
Conclusion
Do Won Hwang's contributions to pharmaceutical innovation demonstrate his commitment to improving healthcare solutions. His work in developing treatments for myositis showcases the potential of isolated mitochondria in medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile